Terms: = Colorectal cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Prognosis
13 results:
1. Elevated expression of the myb proto-oncogene like 2 (mybL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
[TBL] [Abstract] [Full Text] [Related]
2. Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report.
Zheng S; Li H; Lin Y; Xie Y; Yin Z; Ge W; Yu T
Anticancer Drugs; 2022 Jan; 33(1):e548-e554. PubMed ID: 34321419
[TBL] [Abstract] [Full Text] [Related]
3. c-myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition.
Qu X; Yan X; Kong C; Zhu Y; Li H; Pan D; Zhang X; Liu Y; Yin F; Qin H
Cancer Sci; 2019 Oct; 110(10):3183-3196. PubMed ID: 31338937
[TBL] [Abstract] [Full Text] [Related]
4. Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver.
Hass HG; Vogel U; Scheurlen M; Jobst J
Oncology; 2018; 95(4):211-219. PubMed ID: 29920486
[TBL] [Abstract] [Full Text] [Related]
5. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent colorectal Adenocarcinoma.
Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
[TBL] [Abstract] [Full Text] [Related]
6. c-myb regulates NOX1/p38 to control survival of colorectal carcinoma cells.
Pekarčíková L; Knopfová L; Beneš P; Šmarda J
Cell Signal; 2016 Aug; 28(8):924-36. PubMed ID: 27107996
[TBL] [Abstract] [Full Text] [Related]
7. High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting myb and VEGFR2.
Yang IP; Tsai HL; Huang CW; Lu CY; Miao ZF; Chang SF; Juo SH; Wang JY
Oncotarget; 2016 Apr; 7(14):18837-50. PubMed ID: 26934556
[TBL] [Abstract] [Full Text] [Related]
8. Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction.
Wang M; Wei X; Shi L; Chen B; Zhao G; Yang H
Int J Mol Med; 2014 Apr; 33(4):1019-26. PubMed ID: 24535227
[TBL] [Abstract] [Full Text] [Related]
9. Induction of T cell-mediated immunity using a c-myb DNA vaccine in a mouse model of colon cancer.
Williams BB; Wall M; Miao RY; Williams B; Bertoncello I; Kershaw MH; Mantamadiotis T; Haber M; Norris MD; Gautam A; Darcy PK; Ramsay RG
Cancer Immunol Immunother; 2008 Nov; 57(11):1635-45. PubMed ID: 18386000
[TBL] [Abstract] [Full Text] [Related]
10. p38MAPK delta controls c-myb degradation in response to stress.
Pani E; Ferrari S
Blood Cells Mol Dis; 2008; 40(3):388-94. PubMed ID: 18006338
[TBL] [Abstract] [Full Text] [Related]
11. Effect of the farnesyl transferase inhibitor L-744,832 on the colon cancer cell line DLD-1 and its combined use with radiation and 5-FU.
Kavgaci H; Ozdemir F; Ovali E; Yavuz A; Yavuz M; Aydin F
Chemotherapy; 2005 Oct; 51(6):319-23. PubMed ID: 16224182
[TBL] [Abstract] [Full Text] [Related]
12. C-myb, serum P-53M, genetic instability, labeling index and endoscopic findings in patients with adenoma or colorectal cancer.
Assisi D; Grassi A; La Penta R; Stigliano V; Greco C; Cianciulli AM; Giannarelli D; Casale V
J Exp Clin Cancer Res; 2004 Sep; 23(3):469-75. PubMed ID: 15595638
[TBL] [Abstract] [Full Text] [Related]
13. c-myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.
Biroccio A; Benassi B; D'Agnano I; D'Angelo C; Buglioni S; Mottolese M; Ricciotti A; Citro G; Cosimelli M; Ramsay RG; Calabretta B; Zupi G
Am J Pathol; 2001 Apr; 158(4):1289-99. PubMed ID: 11290547
[TBL] [Abstract] [Full Text] [Related]
